AU1123497A - Recombinant hiv and modified packaging cells and method for treating acquired immune deficiency syndrome - Google Patents
Recombinant hiv and modified packaging cells and method for treating acquired immune deficiency syndromeInfo
- Publication number
- AU1123497A AU1123497A AU11234/97A AU1123497A AU1123497A AU 1123497 A AU1123497 A AU 1123497A AU 11234/97 A AU11234/97 A AU 11234/97A AU 1123497 A AU1123497 A AU 1123497A AU 1123497 A AU1123497 A AU 1123497A
- Authority
- AU
- Australia
- Prior art keywords
- immune deficiency
- deficiency syndrome
- acquired immune
- packaging cells
- recombinant hiv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000030507 AIDS Diseases 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000004806 packaging method and process Methods 0.000 title 1
- 208000011580 syndromic disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16041—Use of virus, viral particle or viral elements as a vector
- C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/563,360 US6063374A (en) | 1995-11-28 | 1995-11-28 | Recombinant HIV and modified packaging cells and method for using |
| US563360 | 1995-11-28 | ||
| US563597 | 1995-11-28 | ||
| US08/563,597 US5753490A (en) | 1995-11-28 | 1995-11-28 | Recombinant HIV and modified packaging cells and method for treating acquired immune deficiency syndrome |
| PCT/US1996/018885 WO1997020052A1 (en) | 1995-11-28 | 1996-11-25 | Recombinant hiv and modified packaging cells and method for treating acquired immune deficiency syndrome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1123497A true AU1123497A (en) | 1997-06-19 |
Family
ID=27073263
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU11234/97A Abandoned AU1123497A (en) | 1995-11-28 | 1996-11-25 | Recombinant hiv and modified packaging cells and method for treating acquired immune deficiency syndrome |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP0863988A1 (en) |
| AU (1) | AU1123497A (en) |
| WO (1) | WO1997020052A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999004026A2 (en) * | 1997-07-18 | 1999-01-28 | Chiron Corporation | Lentiviral vectors |
| US5994136A (en) | 1997-12-12 | 1999-11-30 | Cell Genesys, Inc. | Method and means for producing high titer, safe, recombinant lentivirus vectors |
| JP2002508338A (en) * | 1997-12-12 | 2002-03-19 | ナルディニ,ルイジ | Therapeutic use of lentiviral vectors |
| ATE368122T1 (en) | 1999-04-29 | 2007-08-15 | Cell Genesys Inc | METHOD AND MEANS FOR PRODUCING SAFE HIGH TITRE RECOMBINANT LENTIVIRAL VECTORS |
| CN109810953A (en) * | 2019-01-07 | 2019-05-28 | 西安彤盛生物科技有限公司 | The recombination the Temple of Heaven strain oncolytic vaccinia virus of removal TK gene and its preparation and application |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5306631A (en) * | 1987-08-21 | 1994-04-26 | University Of Colorado Foundation, Inc. | Compositions and method for inhibition of HIV production |
| US5206353A (en) * | 1988-07-23 | 1993-04-27 | The United States Of America As Represented By The Department Of Health And Human Services | CD-4/cytotoxic gene fusions |
-
1996
- 1996-11-25 WO PCT/US1996/018885 patent/WO1997020052A1/en not_active Ceased
- 1996-11-25 AU AU11234/97A patent/AU1123497A/en not_active Abandoned
- 1996-11-25 EP EP96942059A patent/EP0863988A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO1997020052A1 (en) | 1997-06-05 |
| EP0863988A1 (en) | 1998-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1074997A (en) | Controlled atmosphere package | |
| AU2366895A (en) | Method for heat-treating wood and wood products | |
| AU696741B2 (en) | Packages and their manufacturing process | |
| AU8153594A (en) | Device and method for palletizing unstable articles | |
| AU6344794A (en) | Consolidatable particulate material and well treatment method | |
| AU5052093A (en) | Laminating method and products made thereby | |
| EP0808274A4 (en) | Opening and lowering cartons onto article groups | |
| AU2040695A (en) | Method and system for inspecting packages | |
| AU1131995A (en) | Conveyor system for divergence and convergence | |
| AU4305197A (en) | Method and apparatus for packaging flat articles | |
| AU4277789A (en) | Packaging method and apparatus | |
| AU7767794A (en) | Packages and their manufacture | |
| AU6364790A (en) | Packaging machine and method | |
| AU7938294A (en) | Method for controlled modification of enzymes, enzymes modified in this way and the use of such enzymes | |
| AU7795191A (en) | Vapor clarification system and method | |
| AU4508689A (en) | Recombinant pdgf and methods for production | |
| EP0728678A3 (en) | Microwaveable food package, and method for manufacturing same | |
| AU1123497A (en) | Recombinant hiv and modified packaging cells and method for treating acquired immune deficiency syndrome | |
| AU4641096A (en) | Paperboard package and method for forming same | |
| HUP9700074A3 (en) | Low molecular yeast active substance extract and process for preparing the same | |
| GB9304521D0 (en) | Improved alumoxane,method for its preparation and polymerisation process using such alumoxane | |
| AU7059498A (en) | Aseptic packaging process and apparatus | |
| AU6060694A (en) | Method for treating acquired immune deficiency syndrome | |
| AU2172097A (en) | Infusion packages and methods for their manufacture | |
| AU8968598A (en) | Bovine footrot treatment and prevention |